论文部分内容阅读
目的探讨院前溶栓治疗ST段抬高型急性心肌梗死的临床疗效。方法选取48例ST段抬高型心肌梗死患者,给与所有患者进行尿激酶静脉溶栓治疗,观察患者血管再通率,再灌注心率失常及并发症发生情况。结果有6例出现轻微并发症,有24例患者出现再灌注心律失常,无溶栓冠脉再通的有12例,3例患者因梗死面积较大导致死亡。结论 ST段抬高型急性心肌梗死进行院前溶栓治疗,可降低在院内的时间,且提高溶栓在通率,将低并发症发生率,有效的降低死亡率,且该方法具有简单易行、安全等优点,治疗效果明显,值得临床广泛的推广及应用。
Objective To investigate the clinical effect of prehospital thrombolysis on ST segment elevation acute myocardial infarction. Methods Forty-eight patients with ST-segment elevation myocardial infarction were enrolled in this study. Thrombolytic therapy with urokinase was given to all patients. The recanalization rate, reperfusion arrhythmia and complication were observed. Results There were 6 cases of minor complications, 24 cases of reperfusion arrhythmia, no thrombolysis coronary recanalization in 12 cases, 3 patients died due to larger infarct size. Conclusion ST-segment elevation acute myocardial infarction in pre-hospital thrombolytic therapy can reduce the time in the hospital, and improve thrombolysis in the pass rate, the incidence of low complication, effective in reducing mortality, and the method is simple and easy Line, safety and other advantages, the treatment effect is obvious, it is widely clinical application and promotion.